Incannex Healthcare Inc. (IXHL): Cash & Equivalents
$15.04M
As of 2025-06-30
$74.45M
As of 2026-03-31
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-06-30 | $15.04M | +156.7% | 2025-09-29, Balance as of period end |
| 2024-06-30 | $5.86M | -73.5% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $22.12M | n/a | 2024-09-30, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Incannex Healthcare Inc. (IXHL) | 2025-06-30 | $15.04M | +156.7% |
| Actinium Pharmaceuticals, Inc. (ATNM) | 2025-12-31 | $48.00M | -34.2% |
| iBio, Inc. (IBIO) | 2026-06-30 | $56.40M | +557.1% |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | $4.75M | +21.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $44.27M | -32.7% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $38.34M | -51.0% |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $15.86M | -88.2% |
| Serina Therapeutics, Inc. (SER) | 2025-12-31 | $3.06M | -16.8% |
Compare IXHL, ATNM, IBIO, SILO side by side · Screen every company in Pharmaceutical Preparations ↗